Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Wipro Limited — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.73 (market cap $58.74B), while Wipro Limited trades at $1.71 (market cap $16.22B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 3.6× Wipro Limited's market cap, and Wipro Limited pays the higher dividend (5.19%). Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days and Wipro Limited for 41 Days on average.
| TAK | WIT | |
|---|---|---|
Market Cap | $58.74B | $16.22B |
Volume | 3,110,994 | 9,028,667 |
Sector | Health | Technology |
52-Week High | $19.05 | $3.06 |
52-Week Low | $13.23 | $1.61 |
Typical Hold Time | 1 Days | 41 Days |
Enterprise Value | $86.65B | $14.33B |
Dividend Yield | 3.33% | 5.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WIT trades at $1.715, up 2.69% today, amid a mixed technical and fundamental backdrop. The stock shows bearish technical signals with recent earnings misses but maintains solid profitability and cash flow. Recent news highlights AI-driven productivity gains and strategic partnerships, though revenue growth remains subdued. Analyst sentiment is cautious with a majority hold rating.
The outlook is balanced: valuation appears reasonable with a P/E of 12.78, and strong cash flow supports stability. However, earnings misses and bearish technicals pose near-term risks. Investment appeal hinges on execution of AI initiatives and revenue acceleration against competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
